Changes in Lung Volume Parameters Regarding the Received Dose in the Lobes of the Lungs After Locoregional Radiotherapy of Breast Cancer

Overview

Journal Rep Pract Oncol Radiother

Specialty Oncology

Date 2019 Oct 30

PMID 31660048

Citations 1

Authors

Mahsa Abdemanafi

Mohammad Bagher Tavakoli

Ali Akhavan

Iraj Abedi

Affiliations

Soon will be listed here.

Abstract

Aim: The purpose of this study was to evaluate ΔLVP and correlate them with MLD and V20 in the lobes of the lung.

Background: Radiation-induced lung injury after breast irradiation is controversial. The incidence of such an injury could have negative consequences on breast cancer patients.

Materials And Methods: Twenty-three women treated with Breast-conserving surgery, chemotherapy, and locoregional RT underwent body plethysmography pre-RT and 3 and 6 months post-RT. Statistical analysis was used to evaluate ΔLVP over time and relate them with MLD, V20, age, and concurrent hormonal therapy.

Results: LVP decreased after 3 months and then showed a slight improvement by returning partially to their pre-RT values after 6 months. The mean ΔLVP was -0.64% for one Gy increase of MLD and -0.34% for one percent increase of V20 after 3 months. After 6 months, only ΔVC showed 0.45% reduction with MLD in the upper lobe. Finally, there was no significant correlation between ΔLVP with respect to age and concurrent hormonal therapy.

Conclusions: The results of this study showed that lung volume changes were not a cause for concern in breast cancer patients. There are three reasons to support this conclusion. Lung volume changes and percentage reductions in LVP for each Gy increase of MLD and each percentage increase of V20 in each lobe were small; patients were asymptomatic during the follow-up period; and LVP showed partial improvements after 6 months.

Citing Articles

CT findings of acute radiation-induced pneumonitis in breast cancer.

Jung W, Shim S, Kim K Br J Radiol. 2021; 94(1124):20200997.

PMID: 34111374 PMC: 8764924. DOI: 10.1259/bjr.20200997.

References

Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

Lind P, Rosfors S, Wennberg B, Glas U, BEVEGARD S, Fornander T . Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol. 1999; 49(3):245-54. DOI: 10.1016/s0167-8140(98)00121-2. View

Galvin I, Drummond G, Nirmalan M . Distribution of blood flow and ventilation in the lung: gravity is not the only factor. Br J Anaesth. 2007; 98(4):420-8. DOI: 10.1093/bja/aem036. View

Whelan T . Use of conventional radiation therapy as part of breast-conserving treatment. J Clin Oncol. 2005; 23(8):1718-25. DOI: 10.1200/JCO.2005.11.018. View

Blom Goldman U, Svane G, Anderson M, Wennberg B, Lind P . Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer. Acta Oncol. 2014; 53(10):1373-9. DOI: 10.3109/0284186X.2014.934967. View

Yavas G, Yavas C, Acar H, Toy H, Yuce D, Ata O . Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study. Support Care Cancer. 2012; 21(3):811-7. DOI: 10.1007/s00520-012-1584-7. View

Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P . The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol. 2009; 91(3):421-6. DOI: 10.1016/j.radonc.2008.12.002. View

Krengli M, Sacco M, Loi G, Masini L, Ferrante D, Gambaro G . Pulmonary changes after radiotherapy for conservative treatment of breast cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2007; 70(5):1460-7. DOI: 10.1016/j.ijrobp.2007.08.050. View

Bentzen S, Skoczylas J, Overgaard M, Overgaard J . Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst. 1996; 88(13):918-22. DOI: 10.1093/jnci/88.13.918. View

10.

Spyropoulou D, Leotsinidis M, Tsiamita M, Spiropoulos K, Kardamakis D . Pulmonary function testing in women with breast cancer treated with radiotherapy and chemotherapy. In Vivo. 2009; 23(5):867-71. View

11.

Jaen J, Vazquez G, Alonso E, De Las Penas M, Diaz L, Heras M . Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: a prospective study with 7-year follow-up. Int J Radiat Oncol Biol Phys. 2012; 84(5):e565-70. DOI: 10.1016/j.ijrobp.2012.07.003. View

12.

Lind P, Wennberg B, Gagliardi G, Fornander T . Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat. 2001; 68(3):199-210. DOI: 10.1023/a:1012292019599. View

13.

Jaen J, Vazquez G, Alonso E, Leon A, Guerrero R, Almansa J . Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study. Int J Radiat Oncol Biol Phys. 2006; 65(5):1381-8. DOI: 10.1016/j.ijrobp.2006.03.008. View

14.

Aref A, Thornton D, Youssef E, He T, Denton L, Ezzell G . Dosimetric improvements following 3D planning of tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2000; 48(5):1569-74. DOI: 10.1016/s0360-3016(00)00808-7. View

15.

Nielsen M, Berg M, Pedersen A, Andersen K, Glavicic V, Jakobsen E . Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol. 2013; 52(4):703-10. DOI: 10.3109/0284186X.2013.765064. View

16.

Theuws J, Kwa S, Wagenaar A, Seppenwoolde Y, Boersma L, Damen E . Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 1999; 49(3):233-43. DOI: 10.1016/s0167-8140(98)00117-0. View

17.

Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View

18.

Smith L, Mendenhall N, Cicale M, Block E, Carter R, Million R . Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys. 1989; 16(1):79-84. DOI: 10.1016/0360-3016(89)90013-8. View

19.

Lind P, Gagliardi G, Wennberg B, Fornander T . A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol. 1997; 36(5):509-15. DOI: 10.3109/02841869709001307. View

20.

Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21(1):109-22. DOI: 10.1016/0360-3016(91)90171-y. View